about
Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid IntermediatesType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightAdiponectin, driver or passenger on the road to insulin sensitivity?Linking obesity with type 2 diabetes: the role of T-betDihydroceramides: From Bit Players to Lead ActorsFatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicityLipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesThe Metabolic Implications of Glucocorticoids in a High-Fat Diet Setting and the Counter-Effects of ExerciseAutophagy regulates sphingolipid levels in the liverBile acid signaling in metabolic disease and drug therapyMetabolic features of chronic fatigue syndromeSphingolipids and phospholipids in insulin resistance and related metabolic disorders.Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor.Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling.Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of ObesityHepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.Cross-species gene expression analysis identifies a novel set of genes implicated in human insulin sensitivityMetabolic remodeling of white adipose tissue in obesityCeramides and glucosylceramides are independent antagonists of insulin signalingBile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice.Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.Metabolically normal obese people are protected from adverse effects following weight gainSphingolipid metabolites in inflammatory disease.Rom2-dependent phosphorylation of Elo2 controls the abundance of very long-chain fatty acids.C16:0-ceramide signals insulin resistancePlasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study.Convergence and divergence of genetic and modular networks between diabetes and breast cancer.De novo lipogenesis in metabolic homeostasis: More friend than foe?LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes.Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic SyndromeActivated Kupffer cells inhibit insulin sensitivity in obese mice.Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism.MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance.Synthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.
P2860
Q26739957-0DF2FF24-E93A-4485-95D0-DF1AE1085A4DQ26752583-96153DFA-F24C-4C12-BEDE-E863B1D39954Q26827971-2E3A9CB1-F425-4560-ABE2-2018E3CAB6D0Q26830915-938B16CC-D66B-4C21-B3EE-5C28EF2E27A1Q26851948-E1F602B4-2AD7-4C53-845C-C857164A4B28Q27311488-159ACD42-0878-4FEF-B331-C635C9EC8BBAQ28073169-0B9CCC0D-5EE0-4C63-B3CF-E0EF7CA5B970Q28076700-C6ED154D-A08F-4E35-891F-468E7C78BA5AQ28115515-A1AEC491-FA44-4630-B91D-DF64C002D520Q28244875-2997CF07-5747-40D2-BAB3-C53D5B205AFCQ28829926-D1E28EBA-A2EA-410F-B019-9226DE320498Q30241943-1E253C1C-9045-4614-B677-F356156DB0E1Q30371532-51894A7F-1CC6-44C2-B0BB-BCD23ADDF200Q30536570-9FEBCCA0-07FC-4B30-B644-ADA378655D15Q33603593-930592ED-1D3A-47EE-9505-600ED0EA71E1Q33637396-D29BE1F2-F47B-41D2-B01A-A2BD6A9707C3Q33786729-B2D7F7F6-D167-47F8-B050-BF80D79C5FD3Q33794679-626A9668-E7ED-4544-81D7-3101609F3A5FQ33831711-40681D4B-4E5C-4F1E-AE53-D6D295CAFA25Q33917888-7AADD523-E63D-4115-BCD3-F6B6E7B2BBB5Q34001327-71A7B08F-0CB5-4311-9C3E-37961A840A5FQ34384118-BF5DEDD8-D2D6-4109-9164-4F07ECC3E2BEQ34451281-1765F519-60B6-4188-8CAC-2212358D98E0Q34569354-87B61437-B5E6-4134-AA35-86F40C56815DQ34988375-1A6DEFF7-ED0F-4759-BCC6-CA403E548303Q34996610-050B501E-DA23-4426-977A-06FFC35A2938Q35056761-955067BD-48CB-46B1-9D59-F8A29911754AQ35061720-B1FEE377-CA58-4C8B-866D-5ECAF3EF1870Q35080312-CD4E27CF-B6AB-430B-BFD9-B7DB831A1C81Q35362267-1932B050-DD57-4A86-8F4F-61E1B0C5DE6EQ35537840-365344A7-C9E0-42FD-AD7E-2B8167B31373Q35571951-A14B60B5-B57A-42E7-992E-1001C2B536E7Q35573584-61646315-4E82-49C0-84B8-3ABFC0C6D9F6Q35600641-1040C0CB-626C-46AB-91C9-6015D2B6C122Q35671752-FC28B7CD-4EBC-4EE9-8A29-25FEAF547864Q35774740-561E8B1E-EB68-46E2-90ED-AFC34B0ECA1AQ35780081-6B1A6F13-5A1F-41E5-B3DA-637E3B454936Q35796087-0E58CCE6-7FE1-455E-9D46-A04B8E0C70F8Q35813366-2D1E2F9F-DCBD-4455-BB88-AA99AFB8F184Q35817623-2F3B5800-812B-438A-97E9-1120586A1CA2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A ceramide-centric view of insulin resistance.
@en
type
label
A ceramide-centric view of insulin resistance.
@en
prefLabel
A ceramide-centric view of insulin resistance.
@en
P1433
P1476
A ceramide-centric view of insulin resistance.
@en
P2093
Jose A Chavez
Scott A Summers
P304
P356
10.1016/J.CMET.2012.04.002
P577
2012-05-01T00:00:00Z